- Report
- November 2024
- 180 Pages
Global
From €4106EUR$4,500USD£3,489GBP
- Report
- April 2025
- 150 Pages
Global
From €4426EUR$4,850USD£3,761GBP
- Report
- April 2025
- 150 Pages
Global
From €4426EUR$4,850USD£3,761GBP
- Report
- March 2025
- 150 Pages
Global
From €4426EUR$4,850USD£3,761GBP
- Report
- February 2025
- 150 Pages
Global
From €4426EUR$4,850USD£3,761GBP
- Report
- November 2024
- 150 Pages
Global
From €4426EUR$4,850USD£3,761GBP
- Report
- April 2025
- 150 Pages
Global
From €4426EUR$4,850USD£3,761GBP
- Report
- March 2025
- 150 Pages
Global
From €4426EUR$4,850USD£3,761GBP
- Report
- May 2024
- 210 Pages
Global
From €4061EUR$4,450USD£3,450GBP
- Report
- October 2024
- 180 Pages
Global
From €4106EUR$4,500USD£3,489GBP
- Report
- October 2024
- 250 Pages
Global
From €4516EUR$4,949USD£3,837GBP
- Report
- October 2024
- 200 Pages
Global
From €4516EUR$4,949USD£3,837GBP
- Report
- August 2024
- 200 Pages
Global
From €4516EUR$4,949USD£3,837GBP
- Report
- October 2024
- 200 Pages
Global
From €4516EUR$4,949USD£3,837GBP
- Report
- June 2024
- 120 Pages
Global
From €4558EUR$4,995USD£3,873GBP
- Report
- April 2025
- 183 Pages
Global
From €4558EUR$4,995USD£3,873GBP
- Report
- July 2024
- 151 Pages
Global
From €3296EUR$3,613USD£2,801GBP
€3878EUR$4,250USD£3,295GBP
- Report
- July 2024
- 153 Pages
Global
From €3296EUR$3,613USD£2,801GBP
€3878EUR$4,250USD£3,295GBP
- Report
- March 2025
- 197 Pages
Global
From €4517EUR$4,950USD£3,838GBP
- Report
- March 2025
- 110 Pages
Global
From €2692EUR$2,950USD£2,287GBP

The Eye Disease market within the Optical industry is a rapidly growing sector, with a focus on providing treatments and solutions for a variety of eye conditions. This includes the diagnosis and management of conditions such as glaucoma, cataracts, macular degeneration, and diabetic retinopathy. Companies in this market are developing innovative technologies to improve the accuracy and speed of diagnosis, as well as treatments to improve patient outcomes.
The Eye Disease market is also focused on providing solutions to improve patient access to care, such as telemedicine and remote monitoring. This is helping to reduce the burden on healthcare systems and improve patient outcomes.
Companies in the Eye Disease market include Alcon, Bausch + Lomb, Carl Zeiss Meditec, Essilor, Hoya, Johnson & Johnson Vision, Novartis, and Topcon. Show Less Read more